Big Move For Matinas BioPharma Holdings, Inc.
Mon, Apr 01, 2024 at 07:11 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) shot up at $0.37, a gain of 36.5%. On Mon, Apr 01, 2024, MTNB:NYSEMKT hit a New 2-Week High of $0.37. The stock got featured on our News Catalysts scanner on Wed, Mar 27, 2024 at 05:17 PM in the 'INVESTOR UPDATE' category. From Mon, Mar 18, 2024, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Fri, Mar 22, 2024 at $0.43 with a volume of 22M+.
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- Vast Renewables Limited (VSTE:NASDAQ), 157.61%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 151.02%
- Vinco Ventures Inc. (BBIG:NASDAQ), 87.5%
- two Class A (TWOA:NYSE), 71.47%
- Mediaco Holding Inc. (MDIA:NASDAQ), 55.47%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 41.67%
- IM Cannabis Corp. (IMCC:NASDAQ), 40.02%
- SPAR Group, Inc. (SGRP:NASDAQ), 39.23%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 39.13%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 36.46%